Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06584370 · ClinicalTrials.gov registry record · NA
Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation
A NA study of Atrial Fibrillation and Cardiac Catheterization, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT06584370: Completed NA study of Atrial Fibrillation and Cardiac Catheterization, sponsored by Henry Ford Health System.
NCT06584370 is a NA study of Atrial Fibrillation and Cardiac Catheterization that has completed, run by Henry Ford Health System. The registered enrollment target is 13 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06584370, a NA study of Atrial Fibrillation and Cardiac Catheterization, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.
Conditions Studied
Interventions
- PROCEDURE Pericardial insufflation with carbon dioxide through a transatrial microcatheter
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT06584370 record still lists
NCT06584370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower).
The record links to 9 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Pericardial insufflation with carbon dioxide through a transatrial microcatheter is the first listed.
NCT06584370 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06584370 about?
NCT06584370 is a clinical study titled "Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation". We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.
What is the current status of trial NCT06584370?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2014-05. Estimated completion is 2015-08.
What conditions does trial NCT06584370 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Cardiac Catheterization, Cardiac Surgical Procedures, Left Atrial Appendage Ligation, Pericardium.
What interventions are being tested in trial NCT06584370?
The interventions under investigation include: Pericardial insufflation with carbon dioxide through a transatrial microcatheter (PROCEDURE).
Who is sponsoring clinical trial NCT06584370?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06584370 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06584370's enrollment target sits among peer trials
13 198th of 202 higher than 4 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia